Alnylam Pharmaceuticals Market Sentiment

Alnylam Pharmaceuticals Inc

ALNYNASDAQ

Trade with Public

$247.86

1.120.45%

마지막 업데이트: Oct 1, 9:30 AM

$247.86

1.120.45%

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Alnylam Pharmaceuticals Market Sentiment - Benzinga

Alnylam Pharmaceuticals Market Sentiment

Market sentiment signals for Alnylam Pharmaceuticals (ALNY): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▼ 7.2% short float

Options Flow▲ 0.47 P/C ratio

Insider Activity— N/A

Analyst Consensus

Buy

33 analysts

Options Flow (P/C)

0.47

More calls — Bullish

226 calls · 106 puts

Avg Consensus PT

$418

+68.8%

Highest Price Target

$583

+135.2%

Citigroup

Lowest Price Target

$256

+3.3%

Wells Fargo

Short Interest

7.2%

Rising — Bearish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 30, 2026	JP Morgan	Jessica Fye—	+48.9%	$375 → $369	Maintained	Overweight
Sep 21, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+83.6%	$455 → $455	Maintained	Buy
Sep 8, 2026	Jefferies	Faisal Khurshid—	+4.9%	$230 → $260	Maintained	Hold
Sep 2, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+83.6%	$455 → $455	Maintained	Buy
Aug 19, 2026	BMO Capital	David Lebowitz—	+28.3%	$318	Initiate	Outperform
Aug 14, 2026	Wells Fargo	Derek Archila—	+3.3%	$316 → $256	Maintained	Equal-Weight
Aug 4, 2026	Truist Securities	Danielle Brill—	+27.1%	$410 → $315	Maintained	Buy
Aug 4, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+83.6%	$485 → $455	Maintained	Buy
Aug 3, 2026	Raymond James	Martin Auster—	+69.5%	$420 → $420	Upgrade	Outperform→Strong Buy
Aug 3, 2026	Citigroup	Eric Joseph—	+37.2%	$380 → $340	Maintained	Buy
Aug 3, 2026	Barclays	Eliana Merle—	+81.6%	$527 → $450	Maintained	Overweight
Jul 31, 2026	JP Morgan	Jessica Fye—	+51.3%	$400 → $375	Maintained	Overweight
Jul 31, 2026	RBC Capital	Luca Issi—	+41.2%	$445 → $350	Maintained	Outperform
Jul 31, 2026	Morgan Stanley	Michael Ulz—	+21.0%	$400 → $300	Maintained	Equal-Weight
Jul 31, 2026	Oppenheimer	Kostas Biliouris—	+41.2%	$500 → $350	Maintained	Outperform
Jul 31, 2026	Wells Fargo	Derek Archila—	+27.5%	$377 → $316	Maintained	Equal-Weight
Jul 31, 2026	Stifel	Paul Matteis—	+28.3%	$444 → $318	Maintained	Buy
Jul 31, 2026	Chardan Capital	Keay Nakae—	+71.5%	$425 → $425	Maintained	Buy
Jul 30, 2026	Needham	Joseph Stringer—	+44.0%	$510 → $357	Maintained	Buy
Jul 22, 2026	JP Morgan	Jessica Fye—	+61.4%	$420 → $400	Maintained	Overweight
Jul 14, 2026	B of A Securities	Tazeen Ahmad—	+65.4%	$460 → $410	Maintained	Buy
Jul 13, 2026	Truist Securities	Danielle Brill—	+65.4%	$505 → $410	Maintained	Buy
Jul 13, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+95.7%	$470 → $485	Maintained	Buy
Jul 10, 2026	Morgan Stanley	Michael Ulz—	+61.4%	$370 → $400	Maintained	Equal-Weight
Jun 29, 2026	HC Wainwright & Co.	Patrick R. Trucchio—	+89.6%	$510 → $470	Maintained	Buy